DRUG FORMULATIONS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-PHENOXYPHENYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE

ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT

LOSARTAN-CONTAINING MICRO TABLET FOR PEDIATRIC APPLICATIONS

PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME

TREATMENT OF GASTROINTESTINAL DISORDERS

PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION

SOLID DISPERSION OF A HER2 INHIBITOR

Pharmaceutical compositions

Pharmaceutical Mixture Comprising Amorphous Pitolisant

Tamper resistant dosage forms

ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID

METHODS FOR TREATING AND MONITORING PARKINSON'S DISEASE

PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR

ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS

Bupropion dosage forms with reduced food and alcohol dosing effects

AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF

COMPOSITIONS OF MICRONIZED SOLABEGRON AND METHODS OF USE

HEMI-CITRATE SALTS OF GABA-A POSITIVE ALLOSTERIC MODULATOR AND CRYSTALLINE FORM THEREOF

FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS

THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS

SYNERGISTIC CANNABINOID ESTERS, THEIR SALTS AND USES THEREOF

PROCESS FOR CONTINUOUS HOT MELT GRANULATION OF LOW SOLUBLE PHARMACEUTICALS

SOLID DOSAGE FORMS OF A PLASMA KALLIKREIN INHIBITOR

METHODS OF TREATING MENTAL AND/OR MOOD DISORDERS USING 2-BROMO-LSD ALONE OR IN COMBINATION WITH A MTOR INHIBITOR

DISINTEGRATING MONOLITHIC MODIFIED RELEASE TABLETS CONTAINING QUADRI-LAYER EXTENDED RELEASE GRANULES

PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF

PHARMACEUTICAL DOSAGE FORMS COMPRISING (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-74-CARBOXAMIDE

MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES

COMPOSITION FOR PHARMACEUTICAL TABLET, PHARMACEUTICAL TABLET USING THE SAME, AND MANUFACTURING METHOD THEREOF

CANCER THERAPY

METHODS OF TREATING INFECTIONS IN OVERWEIGHT AND OBESE PATIENTS USING ANTIBIOTICS

COATED FAMOTIDINE PARTICLE

SYSTEM OF MULTIPLE INTERLOCKING EMBEDMENT

DRUG DELIVERY SYSTEM

PREPARATION METHOD OF AMISULPRIDE TABLET

PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF A GLP-1 RECEPTOR AGONIST

Compounds and combinations thereof for treating neurological and psychiatric conditions

LACOSAMIDE PHARMACEUTICAL COMPOSITION PREPARATION METHOD AND APPLICATIONS THEREOF

COMPOSITIONS AND DOSAGE FORMS FOR TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASIA

PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS SOLID DISPERSIONS AND METHODS OF PREPARATION THEREOF

Bupropion dosage forms with reduced food and alcohol dosing effects

COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

SLEEP-REGULATING TABLET ALLOWING RELEASE BY STAGES AND PREPARATION METHOD THEREOF

TREATMENT OF GASTROINTESTINAL DISORDERS

PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONS

Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancer

MODIFIED RELEASE FORMULATIONS OF METHADONE AND ITS ISOMERS, ESMETHADONE AND LEVOMETHADONE AND DERIVATIVES

A CRYSTALLINE FORM OF (4-METHYL-2-[1,2,3]TRIAZOL-2-YL-PHENYL)-[(R)-3-(3-[1,2,3]TRIAZOL-2-YL-BENZYL)-MORPHOLIN-4-YL]-METHANONE

Amorphous solid dispersions

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

Tamper resistant dosage forms

AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE

ENZYME INHIBITORS AND VIRAL INFECTION THERAPY

METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT

ORALLY DISINTEGRATING PALATABLE FORMULATIONS OF DROTAVERINE AND METHOD OF PREPARATION THEREOF

IMMEDIATE RELEASE MULTILAYER TABLET

Solid Drug Tablets for Implantable Drug Delivery Devices

NOVEL LAPPACONITINE DERIVATIVE AND USE THEREOF

IMMEDIATE RELEASE MULTILAYER TABLET

Low-Dose Stable Formulations of Linaclotide

ORAL SOLID FORMULATION FOR COLON CLEANSING

METHODS AND COMPOSITIONS FOR TREATING PERICARDITIS

Solid Pharmaceutical Compositions for Treating HCV

Combination of dextromethorphan and bupropion for treating depression

Fluorescent proanthocyanidins

Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan

SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE

MINI-TABLET DOSAGE FORM OF A VIRAL TERMINASE INHIBITOR AND USES THEREOF

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS

PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS

Solid forms and methods of preparing the same

ORAL PREPARATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

TABLET COMPRISING MODOFLANER AS AN ACTIVE COMPONENT

COMPOSITIONS COMPRISING SPIRULINA COMPONENTS

CRF RECEPTOR ANTAGONISTS AND METHODS OF USE

Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient Subpopulations

Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump Inhibitors

Methods of administering Belumosudil for treatment of chronic graft versus host disease

PHARMACEUTICAL COMPOSITIONS OF SITAGLIPTIN

Methods and compositions for treating retina-associated disease using CCR3-inhibitors

Compounds and combinations thereof for treating neurological and psychiatric conditions

MONOLITHIC COMPOSITION FOR DUAL-RATE RELEASE WITH HIGH DRUG LOADING

METHODS OF TREATING ACHONDROPLASIA

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

AMORPHOUS SOLID DISPERSIONS

Bupropion dosage forms with reduced food and alcohol dosing effects

Bupropion dosage forms with reduced food and alcohol dosing effects

STABLE ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID

SOLID FORMULATION

COMPOSITION FOR SUSTAINED-RELEASE SOLID DOSAGE FORM, SUSTAINED-RELEASE TABLET USING THE SAME, AND MANUFACTURING METHOD THEREOF

PHARMACEUTICAL COMPOSITIONS

Immediate release dosage form

ALDH-2 inhibitor compounds and methods of use

ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE

METHOD FOR PRODUCING AN AMORPHOUSE SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION FOR STABILIZING ACTIVE PHARMACEUTICAL INGREDIENTS

Delayed Release Compositions of Linaclotide

TABLET FOR ORAL SUSPENSION

PHARMACEUTICAL COMPOSITIONS OF UBROGEPANT AND PROCESS FOR PREPARATION THEREOF

BIPHENYL PYRROLIDINE AND BIPHENYL DIHYDROIMIDAZOLE DERIVATIVES FOR INHIBITING ACTIVITY OF 5-HT7 SEROTONIN RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

METHODS AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES

ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID

Compositions of matter and pharmaceutical compositions

FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES

PHARMACEUTICAL FORMULATIONS

Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome

Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one

Nicotine tablet

Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

Stable Immediate Release Tablet and Capsule Formulations of 1-((2S,5R)-5-((7H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino)-2-Methylpiperidin-1-YL)Prop-2-EN-1-One

Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one

SOLID ORAL COMPOSITION COMPRISING CARBAMATE COMPOUND, AND PREPARATION METHOD THEREFOR

MODIFIED ADENOSINE NUCLEOSIDE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS

METHODS AND COMPOSITIONS FOR INTERFERING WITH EXTRACTION OR CONVERSION OF A DRUG SUSCEPTIBLE TO ABUSE

PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF

SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION OF FUSED TRICYCLIC ?-AMINO ACID DERIVATIVE AND PREPARATION METHOD THEREFOR

COMBINATION DRUG FOR THE CONTROL AND MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Immediate release multilayer tablet

SORAFENIB PHARMACEUTICAL COMPOSITION WITH HIGH BIOAVAILABILITY AND USE THEREOF

Tamper resistant dosage forms

Abuse-deterrent dosage forms containing esketamine

HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR

Tamper Resistant Pharmaceutical Formulations

Opioid receptor modulator dosage formulations

PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR TREATMENT OF PAIN

IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS

Orodispersible dosage unit containing an estetrol component

FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

PROGESTOGEN-ONLY ORAL CONTRACEPTION

PHARMACEUTICAL FORMULATIONS COMPRISING TADALAFIL

CONFORMAL COATING OF CELLS FOR IMMUNOISOLATION

NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE

INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS

TABLET DOSAGE FORMS FOR LIPID-BASED DRUG DELIVERY SYSTEMS

ORAL CAVITY POLYMERIC DELIVERY SYSTEMS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof

Amorphous kinase inhibitor formulations and methods of use thereof

Tamper resistant dosage forms

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

ORAL FORMULATIONS AND USES THEREOF

STABLE SOLID FORMULATION OF AZILSARTAN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

WATER-SOLUBLE ARTESUNATE-BASED THERAPY FOR CORONAVIRUS INFECTION

SOLID DOSAGE FORMS OF PALBOCICLIB

Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

PHARMACEUTICAL COMPOSITIONS COMPRISING A DIAMINOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PROCESSES FOR PREPARING THE SAME

Highly Compactable and Durable Direct Compression Excipients and Excipient Systems

METHODS AND SYSTEMS FOR ASSEMBLING INTRAVESICAL DRUG DELIVERY DEVICES

PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING PROTON PUMP INHIBITOR AND ANTACID, AND METHOD FOR PREPARING SAME

NOVEL MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF TAMSULOSIN AND SOLIFENACIN

TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

PROCESS, COMPOSITIONS, AND CRYSTALLINE FORMS OF SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS

Methylphenidate Extended Release Chewable Tablet

Gastroretentive structured dosage form

METHODS AND FORMULATIONS FOR TREATING AND PREVENTING LONG HAUL CORONAVIRUS (LONG COVID) SYMPTOMS AND SEQUELAE

PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND NIRAPARIB

TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE ACETATE AND NIRAPARIB

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT

AMORPHOUS SOLID DISPERSION OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE

USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

3D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERY

Fast Disintegrating Cannabinoid Tablets

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

CONTROLLED-RELEASE TABLET OF IBUPROFEN AND METHOD FOR PREPARING SAME

Treatment of diabetes mellitus

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

PRALSETINIB PHARMACEUTICAL COMPOSITIONS

FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, FILAMENT FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, AND MATERIAL FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT

FAST DISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE

PHARMACEUTICAL COMPOSITION

NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS

SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES

FORMULATION COMPRISING HIF PROLYL HYDROXYLASE INHIBITORS

SUBSTITUTED IMIDAZO[5,1-d][1,2,3,5]TETRAZINES FOR THE TREATMENT OF CANCER

CONTROLLED-RELEASE PHARMACEUTICAL FORMULATIONS FOR TREATMENT OF INTESTINAL INFECTIONS

ORAL SUSTAINED-RELEASE COMPOSITION FOR INSOLUBLE DRUG, AND PREPARATION METHOD THEREOF

COMPOSITION COMPRISING METHYLFOLATE

GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS EXCIPIENT

Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome

NOVEL EXTENDED RELEASE COMPOSITION OF TOFACITINIB, ITS DERIVATIVES AND SALTS

ORAL PHARMACEUTICAL COMPOSITION

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE

NOVEL CLONIDINE FORMULATION

METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER

NOVEL EXTENDED RELEASE COMPOSITION OF 2-(2- AMINOTHIAZOL-4-YL)-N-[4-(2{[(2R)-2-HYDROXY-2-PHENYLETHYL] AMINO} ETHYL) PHENYL] ACETAMIDE

SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF

METHODS AND COMPOSITIONSFOR TREATING VIRAL INFECTIONS

SOLID DOSAGE FORMS OF TAFAMIDIS

SUSTAINED-RELEASE BASE

BINDER

Delayed Release Compositions of Linaclotide

PLASTICIZERS TO IMPROVE RELEASE PERFORMANCE OF AMORPHOUS SOLID DISPERSIONS

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE AS AN ACTIVE INGREDIENT PROVIDES A SPECIFIC PHARMACOKINETIC PARAMETER

Tamper resistant dosage forms

Anti-RNA virus, including anti-SARS-CoV-2 virus, pharmaceutical composition Avifavir

PHARMACEUTICAL RESINATE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

Instant release pharmaceutical preparation of anticoagulant and preparation method therefor

TRIPULSE RELEASE STIMULANT FORMULATIONS

FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS

FORMULATIONS OF A FARNESOID X RECEPTOR AGONIST

Therapeutic compounds and methods

PHARMACEUTICAL FORMULATION

PHENYL PYRROLE AMINOGUANIDINE SALTS AND FORMULATIONS

DELAYED RELEASE NICLOSAMIDE FORMULATION

DISSOLUTION-ENHANCED OLAPARIB COMPOSITION

TABLET, MEDICINE, METHODS FOR PRODUCING THESE, AND KIT

Methods and products for treating subjects with autism spectrum disorders

Ribociclib tablet

COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH

Process for mesalazine solid formulations

7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME

SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR

S1P RECEPTOR MODULATORS

USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

FOSPROPOFOL FORMULATIONS

Use of sublingual dexmedetomidine for the treatment of agitation

MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOF

Orodispersible formulations

PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA

Formulations of (R)-2-amino-3-phenylpropyl carbamate

GRAPE SEED EXTRACTS FOR USE IN THE PREVENTION OR REDUCTION OF STRESS

Pharmaceutical Compositions of Raltegravir

FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203

STABLE PEPTIDE FORMULATIONS FOR ORAL USE

Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof

Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof

Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses

COLONIC PURGATIVE COMPOSITION

Progestogen-only oral contraception

EXTENDED RELEASE COMPOSITIONS COMPRISING PYRIDOSTIGMINE

MUPS TABLET COMPRISING RIBOFLAVIN

PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG BIS(MONOETHANOLAMINE)

COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION

Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one

CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING SAME

PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDES

TABLETS FOR ORAL SUSPENSION CONTAINING RIVAROXABAN

Pharmaceutical compositions of deutetrabenazine and process for preparation thereof

COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND BAICALEIN IN CO-MICRONIZED FORM

ORAL PRODUCT TABLET AND METHOD OF MANUFACTURE

AMORPHOUS SOLID DISPERSION OF PYRAZOLE-AMIDE COMPOUND

Oral dosage form of ticagrelor and preparation method thereof

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

VETERINARY FORMULATIONS COMPRISING RAPAMYCIN AND METHODS OF USING THE SAME FOR TREATING ANIMAL DISEASE

SOLID DISPERSION OF PAN-RAF KINASE INHIBITOR

AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE

DOSAGE FORM FOR NICOTINE REPLACEMENT THERAPY

Therapeutic compositions for treatment of human immunodeficiency virus

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

Pyruvate kinase R (PKR) activating compositions

TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS

SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B6

1-(((2S,3S,4S)-3-ETHYL-4-FLUORO-5-OXOPYRROLIDIN-2-YL)METHOXY)-7-METHOXYISOQUINOLINE-6-CARBOXAMIDE COMBINATIONS AND ORAL DOSAGE FORMS

METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS

Solid Oral Dosage Forms Of Dexamethasone

TABLETS CONTAINING CILOFEXOR AND PHARMACEUTICALLY ACCEPTABLE CARRIERS

SOLID PREPARATION CONTAINING TAFAMIDIS AND METHOD FOR PRODUCING THE SAME

TREATMENT OF NOCTURNAL SYMPTOMS AND MORNING AKINESIA IN SUBJECTS WITH PARKINSON'S DISEASE

PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE

PHARMACEUTICAL COMPOSITION OF DAROLUTAMIDE

Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof

Immediate release multilayer tablet

Compositions of matter and pharmaceutical compositions

REALIZING THE NANO-AMORPHOUS STATE OF MATERIALS INSIDE NANO-POROUS TEMPLATES

Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use

Misoprostol dispersible tablet

Compositions for management of polycystic ovary syndrome

PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE

Formulations/Compositions Comprising a BTK Inhibitor

FAST CONSOLIDATING COMPOUNDS

Drug delivery system

DISPERSIBLE COMPOSITIONS

PELLET AND MULTI-UNIT PELLET SYSTEM (MUPS)

PHARMACEUTICAL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR

SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

Fospropofol formulations

TABLET COMPOSITIONS

MODIFIED RELEASE FORMULATIONS AND USES THEREOF

SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE

CORONAVIRUS THERAPEUTIC AGENT INCLUDING Elaeocarpus sylvestris EXTRACT AS ACTIVE INGREDIENT

Compositions for delivery of reboxetine

Amorphous solid dispersions

COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE

DRUG-POLYMER AMORPHOUS SOLID DISPERSIONS USING LINEAR POLY(ACRYLIC ACID) POLYMERS

Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof

BRIVARACETAM PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1 carboxamide and solid state forms thereof

N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA

LOW-DOSAGE ORODISPERSIBLE OPIOID TABLET AND METHOD FOR PREPARING SAME

PHARMACEUTICAL PREPARATION

Pharmaceutical compositions